RNF138 (Ring Finger Protein 138), a member of the RBR E3 ubiquitin ligase family, plays a significant role in regulating protein turnover and degradation within cells. RNF138 is responsible for the ubiquitination and subsequent degradation of various target proteins, thereby influencing key cellular processes like cell cycle progression, DNA repair, and protein homeostasis. Researchers have been actively investigating the development of small molecules referred to as RNF138 inhibitors, which are designed to specifically disrupt the activity of this ubiquitin ligase enzyme.
RNF138 inhibitors are a class of chemical compounds that have been designed to interfere with the enzymatic function of RNF138. These inhibitors typically function by binding to specific regions of the RNF138 protein, preventing it from interacting with its substrates and catalyzing the ubiquitination process. By inhibiting RNF138 activity, these compounds have the potential to affect the stability and turnover of proteins targeted by RNF138, leading to downstream effects on various cellular pathways. The development and study of RNF138 inhibitors have garnered interest due to their potential implications in understanding the intricate regulatory mechanisms of protein degradation and their role in cellular physiology and pathology. Researchers are actively working on elucidating the specific mechanisms of RNF138 inhibition and exploring its broader implications for basic biological research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a peptide aldehyde that can inhibit proteasome and calpain activities, thus potentially reducing the degradation of proteins ubiquitinated by RNF138. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Pyr-41 is a selective inhibitor of the ubiquitin-activating enzyme E1, which could indirectly inhibit RNF138 by reducing the availability of ubiquitin. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
MLN4924 inhibits the NEDD8-activating enzyme, which is necessary for the neddylation of cullin proteins that regulate the activity of E3 ligases like RNF138. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine is known to inhibit autophagy, which can influence the degradation of ubiquitinated proteins, thereby potentially affecting the function of RNF138. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor that can prevent the degradation of proteins targeted by ubiquitination, indirectly affecting RNF138's role in protein turnover. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Lactacystin is a specific inhibitor of the proteasome, which could lead to the accumulation of RNF138-substrate proteins. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
IU1 specifically inhibits the deubiquitinase USP14, which can affect the deubiquitination process and indirectly modulate RNF138 activity. | ||||||
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $51.00 | 3 | |
NSC 697923 is known to inhibit Ubc13-Uev1A E2 enzyme activity, potentially affecting ubiquitin chains linked to RNF138 substrates. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Gö 6983 is an inhibitor of the E1 enzyme, which initiates the ubiquitination process, thereby indirectly influencing RNF138's activity. | ||||||